OBJECTIVE: The present study aims to compare anti-Mullerian hormone ( @entity248 ) with other ovarian reserve markers and to find a cut-off value of @entity248 for predicting ovarian response towards controlled @entity43 in an @entity52 ( @entity52 ) program. MATERIALS AND METHODS: A prospective analysis was performed in 180 @entity1 undergoing their first @entity52 trial, which is being conducted at a department of assisted reproduction in a tertiary medical center. The main outcome measures were determined as age and antral follicle count as well as the serum concentrations of follicle stimulating hormone, luteinizing hormone (LH), @entity53 (E2), inhibin B and @entity248 . The predictive power of the aforementioned measures in specifying ovarian response was determined by means of discriminate analyses. RESULTS: As expected, day 3 LH levels were significantly high in the poor responder group. The poor responders had significantly lower antral follicle counts, retrieved oocyte number, and mature oocyte counts as well as day 3 @entity248 levels (5.8    2.32 vs. 1.8    0.80 ng/ml). There was a positive correlation with antral follicle count, basal @entity248 , E2 and follicle count on the day of HCG administration and negative correlation with age. The @entity248 level was addressed as the only significant factor in determination of mature oocyte number. A cut-off point for serum @entity248 concentration indicating the value of 2.97 ng/ml was found to predict the poor ovarian response with a sensitivity of 100.0% and a specificity of 89.6%. However, the same cut-off point was not as predictive for the non-conception circumstance. CONCLUSION: The present study concludes that @entity248 is a promising biochemical marker for the prediction of ovarian response and that a cut-off point indicating the value of 2.97 ng/ml can be adopted for this prediction.

Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, @entity53 or antral follicle count in predicting the outcome of XXXX .

@entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian hyperstimulation'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity248 :: ('268', 'Gene') :: ['AMH'] @entity53 :: ('MESH:D004958', 'Chemical') :: ['estradiol'] @entity52 :: ('MESH:C566179', 'Disease') :: ['IVF', 'in vitro fertilization']
@entity52 :: (MESH:C566179,Disease) :: ['in vitro fertilization']
